These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 9609090)

  • 1. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
    Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
    Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats.
    Fishbein I; Waltenberger J; Banai S; Rabinovich L; Chorny M; Levitzki A; Gazit A; Huber R; Mayr U; Gertz SD; Golomb G
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):667-76. PubMed ID: 10712389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein.
    Farb A; Lee SJ; Min DH; Parandoosh Z; Cook J; McDonald J; Pierce GF; Virmani R
    Circ Res; 1997 Apr; 80(4):542-50. PubMed ID: 9118485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
    Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
    Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis.
    Yamasaki Y; Miyoshi K; Oda N; Watanabe M; Miyake H; Chan J; Wang X; Sun L; Tang C; McMahon G; Lipson KE
    Circ Res; 2001 Mar; 88(6):630-6. PubMed ID: 11282898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
    Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
    Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
    Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
    Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery.
    Nishiguchi F; Fukui R; Hoshiga M; Negoro N; Ii M; Nakakohji T; Kohbayashi E; Ishihara T; Hanafusa T
    Atherosclerosis; 2003 Nov; 171(1):39-47. PubMed ID: 14642404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty.
    Nili N; Cheema AN; Giordano FJ; Barolet AW; Babaei S; Hickey R; Eskandarian MR; Smeets M; Butany J; Pasterkamp G; Strauss BH
    Am J Pathol; 2003 Sep; 163(3):869-78. PubMed ID: 12937128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF receptor protein tyrosine kinase expression in the balloon-injured rat carotid artery.
    Panek RL; Dahring TK; Olszewski BJ; Keiser JA
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1283-8. PubMed ID: 9261258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model.
    Gottsauner-Wolf M; Jang Y; Lincoff AM; Cohen JL; Labhasetwar V; Poptic EJ; Forudi F; Guzman LA; DiCorleto PE; Levy RJ; Topol EJ; Ellis SG
    Am Heart J; 1997 Mar; 133(3):329-34. PubMed ID: 9060802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
    Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
    Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
    Millette E; Rauch BH; Defawe O; Kenagy RD; Daum G; Clowes AW
    Circ Res; 2005 Feb; 96(2):172-9. PubMed ID: 15625285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
    Huang C; Mei H; Zhou M; Zheng X
    Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
    Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
    Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.
    Ruef J; Meshel AS; Hu Z; Horaist C; Ballinger CA; Thompson LJ; Subbarao VD; Dumont JA; Patterson C
    Circulation; 1999 Aug; 100(6):659-65. PubMed ID: 10441105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo.
    Myllärniemi M; Frösen J; Calderón Ramirez LG; Buchdunger E; Lemström K; Häyry P
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):159-68. PubMed ID: 10372232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury.
    Majesky MW; Giachelli CM; Reidy MA; Schwartz SM
    Circ Res; 1992 Oct; 71(4):759-68. PubMed ID: 1516153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.